美国SECURE规则评析及其对中国的启示

doi:10.13523/j.cb.2106017

中国生物工程杂志

2021, Vol. 41

Issue (9): 126-135 DOI: 10.13523/j.cb.2106017

产业发展

美国SECURE规则评析及其对中国的启示

刘旭霞(

),杨安珂

华中农业大学文法学院武汉 430070

An Analysis of the U.S. SECURE Rule and Its Enlightenment to China

LIU Xu-xia(

),YANG An-ke

College of Humanities and Law, Huazhong Agricultural University,Wuhan 430070, China

全文: PDF(674 KB) HTML

摘要：

美国农业部动植物卫生检疫局在最近一次生物技术法规的修订中,将原有的关于监管利用基因工程开发的生物体的进口、州际移动和环境释放一章的规定进行了较大幅度的修改,并将之命名为SECURE规则。这一规则采用了新的安全评价方法,将评价的重心从原来的生产方法转移到了产品的特性上。此外,新的规则还通过豁免程序和监管状态审查等程序的设立,进一步简化了监管方式。但SECURE规则也存在着部门立法之间的协调不足、配套机制建设不完善等问题,可能给新规则的实施带来一定的挑战。我国作为转基因技术大国,在农业生物技术及其产品监管的立法上可以批判性地借鉴美国最新的立法实践,为我国生物技术产业的发展提供法治保障。

关键词： 生物技术; 植物病虫害; 安全评价; 监管豁免

Abstract:

In the latest revision of biotechnology regulations, the Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture revised the original regulations on the import, interstate movement and environmental release of organisms developed by genetic engineering to a greater extent. APHIS names it SECURE rule. This rule adopts a new safety evaluation method, shifting the focus of evaluation from the original production method to the characteristics of the product. In addition, the new rules further simplify the supervision method through procedures such as exemption procedures and supervision status review. However, the SECURE rule also has problems such as insufficient coordination between departmental legislation and imperfect construction of supporting mechanisms, which may bring certain challenges to the implementation of the new rules. As a major country of genetically modified technology, China can critically learn from the latest U.S. legislative practice in the legislation of agricultural biotechnology and its product supervision to provide legal protection for the development of the Chinese biotechnology industry.

Key words: Biotechnology Plant pest Safety evaluation Exemption from supervision

收稿日期: 2021-06-10 出版日期: 2021-09-30

ZTFLH:

Q819

通讯作者: 刘旭霞 E-mail: liuxuxia@mail.hzau.edu.cn

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘旭霞
	杨安珂

引用本文:

刘旭霞,杨安珂. 美国SECURE规则评析及其对中国的启示[J]. 中国生物工程杂志, 2021, 41(9): 126-135.

LIU Xu-xia,YANG An-ke. An Analysis of the U.S. SECURE Rule and Its Enlightenment to China. China Biotechnology, 2021, 41(9): 126-135.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2106017 或 https://manu60.magtech.com.cn/biotech/CN/Y2021/V41/I9/126

图1 SECURE规则监管流程

表1 SECURE规则实施时间线

[1]	U.S. Department of Agriculture-Animal and Plant Health Inspection Service. Movement of certain genetically engineered organisms:proposed rules. [2021-03-17]. https://www.govinfo.gov/content/pkg/FR-2019-06-06/pdf/2019-11704.pdf.
[2]	U.S.Department of Agriculture-Animal and Plant Health Inspection Service. Movement of certain genetically engineered organisms:final rules. [2021-03-17]. https://www.aphis.usda.gov/brs/fedregister/BRS_2020518.pdf.
[3]	Board for International Food and Agricultural Development (BIFAD), International Food Policy Research Institute (IFPRI), Association of Public and Land-Grant Universities (APLU). How the United States benefits from agricultural and food security investments in developing countries. [2021-03-24]. https://ebrary.ifpri.org/digital/collection/p15738coll2/id/133419.
[4]	Emma Kovak. USDA relaxed its GMO, gene-edited crop rules-but not enough to foster biotech innovation. [2021-04-09]. https://geneticliteracyproject.org/2020/06/11/viewpoint-usda-relaxed-its-gmo-gene-edited-crop-rules-but-not-enough-to-foster-biotech-innovation/.
[5]	Health Canada-Food and Nutrition. List of non-novel determinations for food and food ingredients. [2021-04-11]. https://www.canada.ca/en/health-canada/services/food-nutrition/genetically-modified-foods-other-novel-foods/requesting-novelty-determination/list-non-novel-determinations.html.
[6]	Greg Jaffe. Analysis: Problematic provisions in new USDA rule for GE plants. [2021-04-06]. https://geneticliteracyproject.org/2020/10/15/analysis-problematic-provisions-in-new-usda-rule-for-ge-plants/.
[7]	Smyth S J, McDonald J, Falck-Zepeda J. Investment, regulation, and uncertainty. GM Crops & Food, 2014, 5(1):44-57.
[8]	U.S.Department of Agriculture-Animal and Plant Health Inspection Service. USDA's biotechnology notification process. [2021-05-07]. https://scholarworks.iupui.edu/bitstream/handle/1805/822/Biotechnology%20notification%20process%20-%20BRS%20factsheet.pdf.
[9]	U.S.Department of Agriculture-Animal and Plant Health Inspection Service. Proposed rule: movement of certain genetically engineered organisms. [2021-05-07]. https://www.federalregister.gov/documents/2019/06/06/2019-11704/movement-of-certain-genetically-engineered-organisms.
[10]	U.S.Department of Agriculture. Questions & answers:sustainable, ecological, consistent, uniform, responsible, efficient (secure) rule confirmation process. [2021-04-17]. https://www.aphis.usda.gov/brs/pdf/q-a-confirmation-process.pdf.
[11]	U.S. Department of Agriculture. Questions & answers:sustainable, ecological, consistent, uniform, responsible, efficient (secure) rule. [2021-04-17]. https://www.aphis.usda.gov/biotechnology/340-secure-rule-qa.pdf.
[12]	刘旭霞, 冯冠南. 美国《国家生物工程食品信息披露标准(实施细则)》制定中公众参与的经验及启示. 华中农业大学学报(社会科学版), 2020(1):153-160, 170.
	Liu X X, Feng G N. Experience and enlightenment of public participation in the formulation of the national bio-engineered food disclosure standard(regulations). Journal of Huazhong Agricultural University (Social Sciences Edition), 2020(1):153-160, 170.

[1]	胡鸢雷,陈彦丞,濮润,姚卫浩,张宏翔. 英国生物技术产业创新创业生态系统的构建与启示[J]. 中国生物工程杂志, 2021, 41(4): 100-105.
[2]	吴函蓉,王莹,黄英明,李冬雪,李治非,方子寒,范玲. 以基地平台为抓手,促进生物技术创新与转化[J]. 中国生物工程杂志, 2021, 41(12): 141-147.
[3]	吴函蓉,王莹,杨力,葛瑶,范玲. 我国生物技术基地平台现状与发展建议[J]. 中国生物工程杂志, 2021, 41(11): 119-123.
[4]	吴函蓉,王莹,李苏宁,桑晓冬,范玲. 我国生物技术基地平台建设政策研究[J]. 中国生物工程杂志, 2021, 41(10): 127-131.
[5]	宋以梅,贾秀伟,李树标,高翠娟. 工业微生物解脂耶氏酵母及其应用研究^*[J]. 中国生物工程杂志, 2020, 40(9): 77-86.
[6]	胡鸢雷,姚卫浩,濮润,张宏翔. 美国创新创业生态系统中生物技术孵化器的作用[J]. 中国生物工程杂志, 2019, 39(12): 103-109.
[7]	赵萍,张博,王学昭. 农业生物技术领域专利态势分析[J]. 中国生物工程杂志, 2018, 38(8): 100-107.
[8]	陈方,陈云伟,丁陈君,郑颖,吴晓燕,罗丹丹,赵秋伟,于波. “一带一路”沿线国家生物技术发展趋势研究[J]. 中国生物工程杂志, 2018, 38(1): 1-14.
[9]	沈平, 武玉花, 梁晋刚, 卢新, 章秋艳, 王颢潜, 刘鹏程. 转基因作物发展及应用概述[J]. 中国生物工程杂志, 2017, 37(1): 119-128.
[10]	陈方, 丁陈君, 陈云伟, 郑颖, 邓勇, 徐萍, 于建荣, 吴林寰, 马俊才, 曾艳, 刘斌. 中国工业生物技术发展态势分析与展望[J]. 中国生物工程杂志, 2016, 36(5): 1-11.
[11]	王旭静, 张欣, 刘培磊, 王志兴. 复合性状转基因植物的应用现状与安全评价[J]. 中国生物工程杂志, 2016, 36(4): 18-23.
[12]	李耿, 刘晓志, 王志明, 高健. 非免疫球蛋白配体药物应用进展[J]. 中国生物工程杂志, 2016, 36(2): 90-95.
[13]	王凯, 张威, 李师翁. 植酸酶及其应用[J]. 中国生物工程杂志, 2015, 35(9): 85-93.
[14]	毛开云, 杨露, 王恒哲, 陈大明. 生物技术药物市场现状与发展趋势[J]. 中国生物工程杂志, 2015, 35(1): 111-119.
[15]	高凯, 任跃明, 王兰, 郭中平, 王军志. 关于我国药典重组DNA技术产品总论的思考[J]. 中国生物工程杂志, 2014, 34(5): 107-115.

Viewed

Full text

Abstract

Cited

Shared

Discussed